{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:58:07Z","timestamp":1786636687951,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Views"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/1995-705x.99226","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T02:21:28Z","timestamp":1343787688000},"page":"42","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of QT interval in \u03b2 thalassemia major patients in comparison with control group"],"prefix":"10.4103","volume":"13","author":[{"given":"MohammadAmin","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"khaheshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koosha","family":"Paydary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1995-705X.99226-1","first-page":"27","volume-title":"Survival and causes of death in major thalassemia","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"key-10.4103\/1995-705X.99226-2","first-page":"574","volume-title":"Survival in medically treated patients with homozygous \u03b2-thalassemia","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1995-705X.99226-3","first-page":"1187","volume-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"key-10.4103\/1995-705X.99226-4","first-page":"899","volume-title":"Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death","author":"Atiga","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key-10.4103\/1995-705X.99226-5","first-page":"859","volume-title":"Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus","author":"Wei","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1995-705X.99226-6","first-page":"327","volume-title":"QT dispersion and sudden unexpected death in chronic heart failure","author":"Barr","year":"1994","journal-title":"Lancet"},{"key":"key-10.4103\/1995-705X.99226-7","first-page":"739","volume-title":"Iron-chelating therapy and the treatment of thalassemia","author":"Olivieri","year":"1997","journal-title":"Blood"},{"key":"key-10.4103\/1995-705X.99226-8","first-page":"1344","volume-title":"QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular dysfunction: A prospective study","author":"Piccirillo","year":"2007","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1995-705X.99226-9","first-page":"322","volume-title":"Increased QT variability in young asymptomatic patients with \u03b2 thalassemia major","author":"Magr\u00fd","year":"2007","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/1995-705X.99226-10","first-page":"754","volume-title":"What causes sudden death in heart failure?","author":"Tomaselli","year":"2004","journal-title":"Circ Res"},{"key":"key-10.4103\/1995-705X.99226-11","first-page":"901","volume-title":"Evaluation of QT dispersion in \u03b2-thalassemia major patients","author":"Ulger","year":"2006","journal-title":"Am J Hematol"},{"key":"key-10.4103\/1995-705X.99226-12","first-page":"359","volume-title":"Cardiac status in well-treated patients with thalassemia major","author":"Aessopos","year":"2004","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/1995-705X.99226-13","first-page":"1187","volume-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"key-10.4103\/1995-705X.99226-14","first-page":"1216","volume-title":"Report on a policy conference of European society of cardiology.The potential for QT prorogation and proarrhythmia by non-antiarrhythmic drugs: Clinical and regulatory implications","author":"Haverkamp","year":"2000","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1995-705X.99226-15","first-page":"2171","volume-title":"Cardiovascular T2-star (T2FNx01) magnetic resonance for the early diagnosis of myocardial iron overload","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1995-705X.99226-16","first-page":"31","volume-title":"QTc Interval and QT Dispersion in Patients with Thalassemia Major: Electrocardiographic (EKG) and Echocardiographic Evaluation","author":"Garadah","year":"2010","journal-title":"Clin Med Insights Cardiol"}],"container-title":["Heart Views"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:59:57Z","timestamp":1786633197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1995-705X.99226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["99226"],"URL":"https:\/\/doi.org\/10.4103\/1995-705x.99226","relation":{},"ISSN":["1995-705X"],"issn-type":[{"value":"1995-705X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}